3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Neoplasms
19
Breast Neoplasms
17
Lung Neoplasms
10
Carcinoma, Non-Small-Cell Lung
7
Prostatic Neoplasms
5
Melanoma
5
Colorectal Neoplasms
5
Brain Neoplasms
5
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Carcinoma, Hepatocellular
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Skin Neoplasms
3
Myeloproliferative Disorders
3
Leukemia, Myeloid, Acute
3
Kidney Neoplasms
3
Head and Neck Neoplasms
3
Uveal Melanoma
2
Recurrence
2
Neoplasm, Residual
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Lung Diseases
2
Glioma
2
Glioblastoma
2
Genetic Predisposition to Disease
2
Fibrosis
2
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Cisplatin
2
tislelizumab
1
radium Ra 223 dichloride
1
peposertib
1
encorafenib
1
cabozantinib
1
binimetinib
1
avelumab
1
alovudine
1
X-Rays
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Propranolol
1
Platinum Compounds
1
Platinum
1
Pemetrexed
1
Nivolumab
1
Laparoscopy
1
Ipilimumab
1
Gemcitabine
1
DNA Mismatch Repair
1
Conversion to Open Surgery
1
Carboplatin
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphatic Metastasis
×
Blood Specimen Collection
×
90 days
×
Clear all
NCT07319104
2026-06-02
FECCO-BioBank
University Hospital, Montpellier
Not yet recruiting
1,000 enrolled